Publications by authors named "Gerd-Ruediger Burmester"

Claim this Profile
I
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe, Gerd-Ruediger Burmester

Lancet· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Echocardiographic follow-up of patients with systemic sclerosis by 2D speckle tracking echocardiography of the left ventricle.
Sebastian Spethmann, Karl Rieper, Gabriela Riemekasten, Adrian C Borges, Sebastian Schattke, Gerd-Ruediger Burmester

Cardiovasc Ultrasound· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT.
Anja Strangfeld, Franka Hierse, Rolf Rau, Gerd-Ruediger Burmester, Brigitte Krummel-Lorenz

Arthritis Res Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis